KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
628.00
-8.00 (-1.26%)
At close: Aug 1, 2025, 3:30 PM KST
KMPHARMACEUTICAL Revenue
KMPHARMACEUTICAL had revenue of 4.08B KRW in the quarter ending March 31, 2025, a decrease of -8.66%. This brings the company's revenue in the last twelve months to 14.09B, down -17.59% year-over-year. In the year 2024, KMPHARMACEUTICAL had annual revenue of 14.47B, down -18.54%.
Revenue (ttm)
14.09B
Revenue Growth
-17.59%
P/S Ratio
1.23
Revenue / Employee
242.90M
Employees
58
Market Cap
17.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.47B | -3.29B | -18.54% |
Dec 31, 2023 | 17.77B | 2.14B | 13.68% |
Dec 31, 2022 | 15.63B | -7.07B | -31.15% |
Dec 31, 2021 | 22.71B | -223.00M | -0.97% |
Dec 31, 2020 | 22.93B | 2.59B | 12.73% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Mar 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hyundai Motor Company | 178.98T |
Hanwha Aerospace | 15.28T |
HD Hyundai Heavy Industries | 15.32T |
Doosan Enerbility | 15.88T |